Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.

Study ID
NCT02919644

Study type
Interventional

Study phase
Phase 2

Study status
Unknown status

Trial Acronym

COREVAX-1

Trial Summary

Single-arm, monocentric trial to assess safety and immunological efficacy of adjuvant vaccination with autologous dendritic cells loaded with autologous tumour homogenate after curative resection for stage IV colorectal cancer

More informations

Trial Starting Date

Dec 02,2016

Requirements

Gender All
Minimum age 19 Years
Maximum age N/A

Enrollement Limit